Collegium Pharmaceutical (COLL) Amortizatization of Intangibles (2018 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Amortizatization of Intangibles of $178000.0 for Q1 2026, down 45.06% year-over-year from $324000.0 in Q1 2025, and down 29.92% quarter-over-quarter from $254000.0 in Q4 2025.
Collegium Pharmaceutical (COLL) Amortizatization of Intangibles (2018 - 2026) Analysis & Trends
Collegium Pharmaceutical's Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $178000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 45.06% year-over-year to $178000.0; the TTM figure through Mar 2026 stood at $926000.0 (down 52.19% YoY), while the FY2025 annual figure was $1.1 million, down 47.14% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $178000.0, down from $254000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $723000.0 in Q2 2024, with the low at $178000.0 in Q1 2026.
- The 4-year median for Amortizatization of Intangibles is $376000.0 (2024), against an average of $401363.6.
- The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles slipped 9.67% in 2024, then slumped 63.49% in 2025.
- Collegium Pharmaceutical's Amortizatization of Intangibles stood at $568000.0 in 2023, then tumbled by 33.8% to $376000.0 in 2024, then sank by 32.45% to $254000.0 in 2025, then slipped by 29.92% to $178000.0 in 2026.
- Business Quant data shows COLL's Amortizatization of Intangibles at $178000.0 in Q1 2026, $254000.0 in Q4 2025, and $230000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Collegium Pharmaceutical | 887.15 Mn | 737.84 Mn | 110.29 Mn | 45,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45,000.00 |
| Jun 30, 2026 | 45,000.00 |
| Mar 31, 2026 | 178,000.00 |
| Mar 31, 2026 | 178,000.00 |
| Dec 31, 2025 | 254,000.00 |
| Dec 31, 2025 | 254,000.00 |
| Sep 30, 2025 | 230,000.00 |
| Sep 30, 2025 | 230,000.00 |
| Jun 30, 2025 | 264,000.00 |
| Jun 30, 2025 | 264,000.00 |
| Mar 31, 2025 | 324,000.00 |
| Mar 31, 2025 | 324,000.00 |
| Dec 31, 2024 | 376,000.00 |
| Dec 31, 2024 | 376,000.00 |
| Sep 30, 2024 | 514,000.00 |
| Sep 30, 2024 | 514,000.00 |
| Jun 30, 2024 | 723,000.00 |
| Jun 30, 2024 | 723,000.00 |
| Mar 31, 2024 | 415,000.00 |
| Mar 31, 2024 | 415,000.00 |